Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -767.13 Thousand CAD | 57.61% |
| 2021 | -1.8 Million CAD | -15.7% |
| 2020 | -1.56 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -138.87 Thousand CAD | -77.84% |
| 2023 Q1 | -78.08 Thousand CAD | 18.97% |
| 2022 FY | -767.13 Thousand CAD | 57.61% |
| 2022 Q3 | -87.05 Thousand CAD | 67.37% |
| 2022 Q2 | -266.82 Thousand CAD | 15.8% |
| 2022 Q1 | -316.89 Thousand CAD | 33.67% |
| 2022 Q4 | -96.36 Thousand CAD | -10.7% |
| 2021 Q3 | -519.61 Thousand CAD | -0.64% |
| 2021 Q1 | -293.54 Thousand CAD | 52.13% |
| 2021 Q2 | -516.32 Thousand CAD | -75.89% |
| 2021 Q4 | -477.78 Thousand CAD | 8.05% |
| 2021 FY | -1.8 Million CAD | -15.7% |
| 2020 Q4 | -613.16 Thousand CAD | -57.87% |
| 2020 Q3 | -388.4 Thousand CAD | 4.59% |
| 2020 Q2 | -407.08 Thousand CAD | -161.61% |
| 2020 Q1 | -155.6 Thousand CAD | 0.0% |
| 2020 FY | -1.56 Million CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 98.931% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 115.609% |
| SQZ Biotechnologies Company | -75.82 Million USD | 98.988% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 95.702% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 100.937% |
| Mesoblast Limited | -84.14 Million USD | 99.088% |
| Propanc Biopharma, Inc. | -1.53 Million USD | 50.058% |
| Genus plc | 6.4 Million USD | 111.986% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 107.874% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | 17.635% |
| Marizyme, Inc. | -34.08 Million USD | 97.749% |
| ContraFect Corporation | -56.88 Million USD | 98.652% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 90.813% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | 83.157% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | 45.283% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | 73.088% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | 72.113% |
| MultiCell Technologies, Inc. | -722.81 USD | -106032.04% |
| Accustem Sciences Inc. | -3.74 Million USD | 79.524% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 98.7% |
| EV Biologics, Inc. | -483.06 Thousand USD | -58.806% |
| Q BioMed Inc. | -3.44 Million USD | 77.736% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 121.67% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -96.918% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | 70.804% |
| Biomind Labs Inc. | -1 Million USD | 24.016% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -4.87 Million USD | 84.279% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 88.461% |
| Skye Bioscience, Inc. | -13.67 Million USD | 94.389% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | 61.382% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -2461.208% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 84.793% |
| IMV Inc. | -38.67 Million USD | 98.016% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 95.166% |
| Curative Biotechnology, Inc. | -1.93 Million USD | 60.306% |
| GB Sciences, Inc. | -1.42 Million USD | 45.996% |
| Alpha Cognition Inc. | -9.7 Million USD | 92.096% |
| HST Global, Inc. | -140.9 Thousand USD | -444.425% |
| CSL Limited | 3.7 Billion USD | 100.021% |
| Halberd Corporation | -75.05 Thousand USD | -922.163% |
| Enzolytics Inc. | -2.14 Million USD | 64.299% |
| Resverlogix Corp. | -12.74 Million USD | 93.983% |
| Affymax, Inc. | -15.04 Million USD | 94.901% |
| SYBLEU INC | -149.18 Thousand USD | -414.233% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | 75.787% |
| argenx SE | -425.04 Million USD | 99.82% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 98.618% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | 26.52% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | 51.427% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | 77.47% |
| AVAX Technologies, Inc. | 6.69 Million USD | 111.462% |
| Zenith Capital Corp. | -8.94 Million USD | 91.422% |
| Genscript Biotech Corporation | -415.79 Million USD | 99.816% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -4303.496% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | 68.756% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -347.283% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 98.605% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | 73.559% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | 22.044% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | 58.853% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.25 Million USD | 38.923% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 61.734% |
| BioStem Technologies, Inc. | -7.77 Million USD | 90.138% |
| ONE Bio Corp. | 13.68 Million USD | 105.607% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -322.698% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | 42.555% |
| Wesana Health Holdings Inc. | -1.12 Million USD | 31.805% |
| Agentix Corp. | -1.37 Million USD | 44.077% |
| LadRx Corporation | -3.82 Million USD | 79.937% |
| Cell Source, Inc. | -4.32 Million USD | 82.264% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -84.638% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -11.672% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -11.672% |
| NovAccess Global Inc. | -2.46 Million USD | 68.901% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | 73.723% |
| Itoco Inc. | -919.14 Thousand USD | 16.538% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | 81.9% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | 31.445% |
| Kadimastem Ltd | -3.04 Million USD | 74.767% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -193.105% |
| CytoDyn Inc. | -18.05 Million USD | 95.752% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -2947.807% |
| Mobile Lads Corp. | -554.55 Thousand USD | -38.334% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -248.573% |
| Qrons Inc. | -643.67 Thousand USD | -19.18% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -35.842% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | 65.598% |
| Rebus Holdings, Inc. | -664 Thousand USD | -15.532% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | 57.764% |
| International Stem Cell Corporation | -663 Thousand USD | -15.706% |
| Bioxytran, Inc. | -3.82 Million USD | 79.919% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -1357.32% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -3671.549% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 97.885% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | 52.588% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -4.253% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | 75.341% |
| Neutra Corp. | -229.48 Thousand USD | -234.283% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 95.626% |
| PureTech Health plc | -146.19 Million USD | 99.475% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 96.43% |
| IXICO plc | -1.43 Million USD | 46.616% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 91.917% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 99.37% |
| CSL Limited | 3.81 Billion USD | 100.02% |
| Cellectis S.A. | -108.85 Million USD | 99.295% |